👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
✓ Verified
Trust score 98/100
Accepting new patients
Dr
Dr Alexander Martin
Oncology
English
7,494+
Patients seen
2
Years in practice
12
Publications
1
Languages spoken
About
Dr Alex Martin is a highly experienced Clinical Oncologist based at West Suffolk and Addenbrooke’s Hospitals. He specialises in the treatment of prostate and bladder (urothelial) cancers, as well as advanced radiotherapy for patients with metastatic disease.
Dr Martin studied medicine at the Universities of Cambridge and Oxford, and completed his specialist oncology training in London. During this time, he spent two years at the CyberKnife Centre in London, gaining extensive experience in some of the most precise forms of radiotherapy available, including stereotactic radiosurgery (SRS) and stereotactic ablative radiotherapy (SABR). He continues to be passionate about using the latest radiotherapy techniques to improve outcomes while minimising side effects for patients.
In his clinical practice, Dr Martin offers a full range of modern cancer treatments, including radiotherapy, hormone therapy, chemotherapy, targeted therapies and immunotherapy. He is the East of England Radiotherapy Network Clinical Lead for SABR and a member of the GenesisCare National SABR Advisory Team. Since 2021, he has been a core member of the GenesisCare MR Linac consultant team, delivering highly targeted radiotherapy for prostate cancer and metastatic disease.
Dr Martin is actively involved in shaping cancer care at a regional
and national level and served on the committee of the British Uro-Oncology
Group from 2016 to 2025.
Dr Martin studied medicine at the Universities of Cambridge and Oxford, and completed his specialist oncology training in London. During this time, he spent two years at the CyberKnife Centre in London, gaining extensive experience in some of the most precise forms of radiotherapy available, including stereotactic radiosurgery (SRS) and stereotactic ablative radiotherapy (SABR). He continues to be passionate about using the latest radiotherapy techniques to improve outcomes while minimising side effects for patients.
In his clinical practice, Dr Martin offers a full range of modern cancer treatments, including radiotherapy, hormone therapy, chemotherapy, targeted therapies and immunotherapy. He is the East of England Radiotherapy Network Clinical Lead for SABR and a member of the GenesisCare National SABR Advisory Team. Since 2021, he has been a core member of the GenesisCare MR Linac consultant team, delivering highly targeted radiotherapy for prostate cancer and metastatic disease.
Dr Martin is actively involved in shaping cancer care at a regional
and national level and served on the committee of the British Uro-Oncology
Group from 2016 to 2025.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Alexander Martin
Education & training
-
2017–2023 MD · Medicine and Surgery
-
2023–2027 Residency · Oncology
-
2027–2028 Fellowship · Subspecialty training
Career & appointments
-
2027-09–2028-08 Junior consultant
Licenses & insurance
Medical licenses
GB — Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
Generali Healthcare · 3,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 986 |
| Annual physical exam | 99395 | 2,676 |
| Vaccination administration | 90471 | 2,372 |
| Minor procedure (skin) | 17110 | 2,891 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 90 min | in_clinic | 450.00 EUR |
| Minor procedure (skin) | 60 min | in_clinic | 180.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 13 · i10: 13
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.2109/euroclin.2025.0 · PMID: 37216458 · cited by 82
-
European registry analysis of Oncology outcomes
DOI: 10.4004/euroclin.2024.1 · PMID: 31345574 · cited by 48
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
Society memberships
- WONCA Europe — Family Doctors — Member · since 2028
- national college of family doctors — Member · since 2028
- European Union of Medical Specialists (UEMS) — Member · since 2028
Patient reviews
- Bedside Manner
- 5.00
- Knowledge
- 5.00
- Wait Time
- 4.75
- Staff Friendliness
- 5.00
- Ease Of Appointment
- 4.90
- Value For Money
- 4.92
- Would Recommend Pct
- 99
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · alex.martin@euroclinics.example
- Accepted intl insurance
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
